Strategic Wealth Investment Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $463K | Buy |
2,493
+299
| +14% | +$55.5K | 0.67% | 39 |
|
|
2025
Q1 | $460K | Sell |
2,194
-49,733
| -96% | -$10.4M | 0.8% | 36 |
|
|
2024
Q4 | $9.23M | Buy |
51,927
+1,010
| +2% | +$179K | 1.02% | 35 |
|
|
2024
Q3 | $10M | Buy |
50,917
+13,085
| +35% | +$2.58M | 1.07% | 39 |
|
|
2024
Q2 | $6.45M | Buy |
+37,832
| New | +$6.45M | 0.81% | 47 |
|
|
2023
Q4 | $790K | Buy |
5,097
+1,822
| +56% | +$282K | 0.12% | 61 |
|
|
2023
Q3 | $488K | Sell |
3,275
-1,590
| -33% | -$237K | 0.09% | 72 |
|
|
2023
Q2 | $655K | Buy |
4,865
+1,253
| +35% | +$169K | 0.1% | 82 |
|
|
2023
Q1 | $576K | Buy |
3,612
+188
| +5% | +$30K | 0.11% | 83 |
|
|
2022
Q4 | $511K | Buy |
3,424
+38
| +1% | +$5.67K | 0.12% | 71 |
|
|
2022
Q3 | $454K | Buy |
3,386
+414
| +14% | +$55.5K | 0.13% | 69 |
|
|
2022
Q2 | $455K | Sell |
2,972
-665
| -18% | -$102K | 0.11% | 93 |
|
|
2022
Q1 | $590K | Buy |
3,637
+7
| +0.2% | +$1.14K | 0.14% | 61 |
|
|
2021
Q4 | $492K | Buy |
3,630
+113
| +3% | +$15.3K | 0.13% | 62 |
|
|
2021
Q3 | $378K | Buy |
3,517
+6
| +0.2% | +$645 | 0.11% | 63 |
|
|
2021
Q2 | $395K | Buy |
3,511
+108
| +3% | +$12.2K | 0.14% | 60 |
|
|
2021
Q1 | $368K | Buy |
3,403
+139
| +4% | +$15K | 0.18% | 57 |
|
|
2020
Q4 | $350K | Sell |
3,264
-62
| -2% | -$6.65K | 0.21% | 64 |
|
|
2020
Q3 | $291K | Buy |
3,326
+193
| +6% | +$16.9K | 0.22% | 70 |
|
|
2020
Q2 | $308K | Sell |
3,133
-141
| -4% | -$13.9K | 0.3% | 63 |
|
|
2020
Q1 | $249K | Sell |
3,274
-139
| -4% | -$10.6K | 0.41% | 38 |
|
|
2019
Q4 | $302K | Buy |
+3,413
| New | +$302K | 0.31% | 43 |
|